Focusing Care – ADHD Expert Shares Current Treatments and Latest Research at Seattle Children’s

Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental disorders that affect children. While patients may first be diagnosed in childhood, ADHD often persists and can be diagnosed at any age. Management of the condition varies as symptoms manifest differently through various milestones in a person’s life. Common ADHD symptoms include trouble […]

Read More →

Seattle Children’s Doctors Use 3D Printing to Help Train International Care Teams on Complex Surgery

Healthcare organizations are increasingly looking to incorporate the use of 3D-printed models to help improve outcomes for pediatric patients in need of very complex surgeries. Doctors at Seattle Children’s are now utilizing 3-D printed models created in the hospital’s Innovation Lab to train international care teams in a highly specialized procedure, known as a slide […]

Read More →

‘An Integral Part of Cancer Care’: How a Seattle Children’s Oncologist Researches and Advocates for Body-Mind Health

Dr. Molly Taylor recently found a long-forgotten journal from her college years. In it, she asked her young adult self: “Do I want to be a pediatric oncologist?” It turns out she did, and she went to medical school after studying psychology and microbiology as an undergrad. Bringing together of all those disciplines, today she’s […]

Read More →

New RSV Vaccine Offering Protection for Infants Approved with the Help of Research from Seattle Children’s

In a major moment for combatting respiratory syncytial virus (RSV), on Sept. 22 the Centers for Disease Control (CDC) recommended an RSV vaccine for pregnant persons that researchers have determined is safe and effective in preventing RSV disease in infants through immunization during pregnancy. The new Pfizer RSV vaccine joins the recently approved monoclonal antibody, […]

Read More →

Seattle Children’s Announces Appointment of Dr. Vittorio Gallo as Chief Scientific Officer

Seattle Children’s has appointed Dr. Vittorio Gallo as senior vice president and chief scientific officer. As senior vice president and chief scientific officer, Dr. Gallo will serve as the principal scientific executive of the health system and partner with Chief Research Operations Officer Dr. Eric Tham and Chief Academic Officer Dr. Leslie Walker-Harding to provide […]

Read More →

9 Questions Answered about Clinical Trials by a Seattle Children’s Cancer Expert

It’s estimated nearly 86,000 adolescents and young adults (AYAs) will be diagnosed with cancer this year; in fact, one-third of patients treated for cancer at Seattle Children’s are AYAs. These 15- to 39-year-olds face the unique challenges of their life stage — finishing high school or college, starting a career, establishing independence, finding a romantic […]

Read More →

Everything You Need to Know About Fall and Winter Vaccinations – Q&A with Seattle Children’s Pediatric Infectious Disease Research Group

As summer starts to cool down, parents are all too familiar with the return of back to school prep and fun fall activities. While families are busy checking off school supply lists and spending more time indoors through the chillier months, it might be easy to overlook the preventive care to help keep children safe […]

Read More →

The Next Generation of Researchers: SCRI Summer Scholars Program Provides Path to Science Careers

This story is part two of an On the Pulse series. Read part one here.  Seattle Children’s Research Institute (SCRI) is one of the nation’s leading pediatric research facilities, with talented investigators who have made stunning breakthroughs in their ongoing efforts to help every child live a full, healthy life. Working to inspire and develop […]

Read More →

Spotlight on Invent@SC’s Future Biotech Leaders: Meet Seattle Children’s Dr. Edward Song

Founded in 2022, the Invent at Seattle Children’s Postdoctoral Scholars Program is a first-in-the nation postdoctoral training program that aspires to develop novel therapeutics at Seattle Children’s. The program is an investment in training talented early career scientists historically underrepresented in biotech in the development of therapeutics for childhood diseases. It seeks to improve the […]

Read More →